News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
Merck & Co., Inc. CEO Plans to Keep Schering-Plough Corporation Headquarters
November 5, 2009
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Bloomberg -- Merck & Co. Chief Executive Officer Richard T. Clark said he plans to keep Schering-Plough Corp.’s headquarters after completing the acquisition of the company.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Merck & Co.
MORE ON THIS TOPIC
Business
Summit snags $2B investment from AstraZeneca, clearing financial overhang
September 29, 2026
·
3 min read
·
Tristan Manalac
China
Novo adds long-term obesity differentiation in up to $2.6B Hengrui deal
September 29, 2026
·
2 min read
·
Annalee Armstrong
Licensing
Merck inks up to $2.13B deal to dine with SciBrunch, gain rights to preclinical KRAS inhibitor
September 28, 2026
·
2 min read
·
Gabrielle Masson
IPO
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
September 25, 2026
·
2 min read
·
Gabrielle Masson
